Concepedia

Penglin Xu

PX

7

Publications

245

Citations

7

H-Index

2019

Active since

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Ningbo University

Penglin Xu is an author at First Affiliated Hospital of Zhengzhou University specializing in cancer genetics, medicine, and gene expression.

ORCID

Top concepts

Publications per year

2019–2024

7

Publications

7

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway

Yan Yu, Dan Zhao, Kongfei Li et al. · Cell Death and Disease · 2020 · 75 citations · Full text

FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer

Mei Ji, Zhao Zhao, Yue Li et al. · Cell Death and Disease · 2021 · 42 citations · Full text

, , +14

The Role of Upregulated <i>DDX11</i> as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma

Jianhao Li, Liwen Liu, Xin Liu et al. · Journal of Cancer · 2019 · 36 citations · Full text

FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer

Mei Ji, Zhao Zhao, Yue Li et al. · Cell Death and Disease · 2021 · 33 citations · Full text

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370

Yan Yu, Penglin Xu, Guangying Cui et al. · Cancer Cell International · 2020 · 26 citations · Full text

Rows per page

1–5 of 7